Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSysgroup Regulatory News (SYS)

Share Price Information for Sysgroup (SYS)

Share Price is delayed by 15 minutes
Get Live Data
18.00    0.00 (0.00%)
Bid:
17.00
Ask:
19.00
Spread: 2.00 (11.765%)
Market Cap: £15.07m
SYS Live PriceLast checked at - London Stock Exchange

Intraday Sysgroup Share Chart

Acquisition

3 Jul 2007 07:02

System C Healthcare plc03 July 2007 System C Healthcare PLC expands into private healthcare sector Acquisition of IQ Systems Services Ltd System C Healthcare PLC ("System C") (AIM:SYS), the provider of specialist ITproducts and services to the healthcare sector announces a significant strategicstep into the private healthcare market with the acquisition of IQ SystemsServices Ltd ("IQ") for a maximum consideration of £2.16m. IQ is a leading supplier of patient management and clinical software solutionsfor private treatment centres and hospitals. Its IQUtopia product is highlyregarded in the private healthcare marketplace and has been deployed at a numberof the most prestigious private sector treatment centres in the countryincluding Sussex Orthopaedic NHS Treatment Centre, Will Adams NHS TreatmentCentre (Gillingham), St Marys NHS Treatment Centre (Portsmouth), Midlands NHSTreatment Centre (Burton) and Eccleshill NHS Treatment Centre (Bradford) amongstothers. IQUtopia complements System C's MedWay Patient Administration andElectronic Patient Record (EPR) software, which is typically deployed intolarger NHS Acute Trusts. The acquisition of IQ accelerates System C's expansion into the privatehealthcare market as well as strengthening its product portfolio. IQ's customersinclude a number of major private healthcare providers including MercuryHealthcare (acquired by Care UK in April 2007), Centres of Clinical Excellence("CCE") and Nations Healthcare (acquired by CCE in June 2007). The consideration for the acquisition is £0.8m in cash on completion, with up toa further £1.36m payable in a mixture of cash and shares over the next 2 yearsdependent on the achievement of performance targets. The cash element of theconsideration is to be funded from the Group's existing resources. In the yearto 31 December 2006, IQ reported turnover of £0.9m, normalised PBT of £0.15mand, as at 31 December 2006, had Gross assets of £0.25m. The board expects theacquisition to be earnings enhancing from day one. (1) System C's Chief Executive, Ian Denley, commented: "We are delighted that IQ has chosen to become a fully integrated part of theSystem C business. We believe that the role of the private sector in most majorhealth economies will be become increasingly important over the medium term, andwith its significant customers and an established and well thought of product,the acquisition of IQ enables System C to expand directly into the privatehealthcare provider market. We will work closely with IQ to enhance IQUtopia, strengthen the professionalservices available to IQ customers, and further expand the strategicrelationship with their clients." John Wyatt Barton, Co-director of IQ, highlighted the product and servicessynergies between the companies: "Working with System C will open up many new opportunities for us. Theirprofessional services capability and their scale are just what our clients havebeen asking for and they have key products which complement IQUtopia. There is a tremendous cultural fit between the two companies and we look forwardto working in close collaboration to meet the exciting new opportunities ahead." ENDS For further information, please contact: System C Healthcare plc Dr Ian Denley, Chief Executive Markus Bolton, Founding Director Tel: 01622 691616 Maitland Emma Burdett/Richard Farnsworth Tel: 020 7379 5151 Collins Stewart Europe Ltd Chris Wells/Mark Connelly Tel: 020 7523 8350 Notes to editors: System C Healthcare plc (www.systemc.com), established in 1983, specialises inthe provision of information systems and solutions to the healthcare sector. Itsstaff have an average of 15 years' healthcare experience and can provide allaspects of systems design, development and deployment services. System C isfounded upon the belief that IT solutions, when effectively implemented, cansignificantly contribute towards improving patient care. System C is a specialist developer and supplier of Patient Administration andElectronic Patient Record Systems to the health service. The company's MedWayproduct is successfully installed at a number of NHS hospitals includingUniversity Hospitals Aintree, Swindon and Marlborough NHS Trust, TamesideHospitals NHS Trust and the Christie, one of the UK's leading cancer hospitals.System C has recently won a £7.5m contract to supply MedWay to the Isle of ManGovernment. System C has helped to install healthcare systems at over 130 NHS Trusts andoffers a wide range of services to Local Service Providers, the NHS andthird-party suppliers. These include programme/project/change management,design, build and test, implementation, training, data migration, interfacingand helpdesk/support services. Within the National Programme for IT (NPfIT),System C people have been involved in the majority of secondary care go-lives todate as well as many GP, community, Single Assessment Programme and child healthdeployments. -------------------------- (1) This statement should not be interpreted as a profit forecast and does notmean that the future earnings per share of System C, following completion of theacquisition of IQ, would necessarily match or exceed the historical earnings pershare of System C. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Apr 20212:53 pmRNSHolding(s) in Company
29th Apr 20212:43 pmRNSHolding(s) in Company
29th Apr 20212:33 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSTrading Update, Notice of Results, New Website
22nd Mar 20211:31 pmRNSHolding(s) in Company
1st Dec 20203:30 pmRNSDealing in Company Shares
23rd Nov 20207:00 amRNSHalf-year Report
11th Nov 20207:00 amRNSInvestor Presentation
28th Oct 20207:00 amRNSTrading Update and Notice of Results
23rd Oct 202011:05 amRNSSecond Price Monitoring Extn
23rd Oct 202011:00 amRNSPrice Monitoring Extension
23rd Oct 202010:28 amRNSHolding(s) in Company
13th Oct 202010:32 amRNSHolding(s) in Company
4th Aug 202010:34 amRNSResult of AGM
24th Jul 20201:55 pmRNSHolding(s) in Company
9th Jul 202012:11 pmRNSNotice of AGM and Annual Report 2020
9th Jul 20207:00 amRNSImplementation of Incentive Plan and initial grant
1st Jul 20207:00 amRNSHolding(s) in Company
30th Jun 20207:00 amRNSFinal Results
22nd Jun 20207:00 amRNSNotice of Results
10th Jun 20207:01 amRNSHolding(s) in Company
2nd Jun 20208:33 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSHolding(s) in Company
27th Apr 20207:00 amRNSHolding(s) in Company
22nd Apr 20203:14 pmRNSHolding(s) in Company
21st Apr 20209:52 amRNSCorrection: Directors Share Purchase
21st Apr 20207:00 amRNSDirectors Share Purchase
20th Apr 20207:00 amRNSTrading and COVID-19 Update
19th Dec 20197:01 amRNSHolding(s) in Company
19th Dec 20197:00 amRNSHolding(s) in Company
25th Nov 20197:00 amRNSHalf-year Report
1st Nov 20197:00 amRNSNotice of Results
20th Sep 201910:43 amRNSResult of AGM
22nd Jul 20197:00 amRNSNotice of AGM and Annual Report 2019
16th Jul 20197:00 amRNSGrants under the Long Term Incentive Plan
27th Jun 20197:00 amRNSDirector Share Purchases
26th Jun 20197:00 amRNSFinal Results
24th Jun 20197:00 amRNSAcquisition of Hub Network Services Limited
21st May 201911:16 amRNSHolding(s) in Company
24th Apr 20197:00 amRNSTrading Update and Notice of Results
6th Mar 20197:00 amRNSContract win
4th Mar 20199:00 amRNSHolding(s) in Company
4th Mar 20199:00 amRNSHolding(s) in Company
27th Feb 20193:39 pmRNSHolding(s) in Company
27th Feb 20193:25 pmRNSHolding(s) in Company
27th Feb 20193:21 pmRNSHolding(s) in Company
25th Feb 20199:30 amRNSDirector/PDMR Shareholding
22nd Feb 201910:17 amRNSResult of GM and Completion of Acquisition
11th Feb 20197:00 amRNSDirector's Share Purchase
6th Feb 201911:07 amRNSAcquisition of Certus IT Limited and Placing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.